Showing results (301-310 of 401) with videos related to

Sort By:
Pageof 41
Transplantation and Cellular Therapy|April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patientsJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Frontiers in Immunology|August 21, 2024
Immune profiling and functional analysis of NK and T cells in ataxia telangiectasiaLea Graafen, Annekathrin Heinze, Nawid Albinger, et al.
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
Haematologica|July 23, 2026
Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemiaJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
British Journal of Haematology|December 6, 2017
CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute LeukemiaRoni Shouval, Annalisa Ruggeri, Myriam Labopin, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Blood Advances|September 22, 2023
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM studyPeter Bader, Ulrike Pötschger, Jean-Hugues Dalle, et al.
Leukemia|October 31, 2022
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemiaValeria Ceolin, Erica Brivio, Harm van Tinteren, et al.
Pageof 41